Jun 13 |
Moderna reaffirms Phase 3 win for next-gen COVID shot
|
Jun 13 |
Moderna says next-gen COVID shot effective in study
|
Jun 13 |
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
|
Jun 12 |
Moderna's RSV Vaccine Has 'Ample Opportunity' Despite Seasoned Competitors, Oppenheimer Says
|
Jun 12 |
7 Struggling Stocks to Sell Before July 2024
|
Jun 12 |
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
|
Jun 11 |
Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
|
Jun 11 |
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
|
Jun 11 |
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
|
Jun 10 |
Moderna (MRNA) Stock Sinks As Market Gains: Here's Why
|